BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 23644138)

  • 1. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.
    Easton DF; Lesueur F; Decker B; Michailidou K; Li J; Allen J; Luccarini C; Pooley KA; Shah M; Bolla MK; Wang Q; Dennis J; Ahmad J; Thompson ER; Damiola F; Pertesi M; Voegele C; Mebirouk N; Robinot N; Durand G; Forey N; Luben RN; Ahmed S; Aittomäki K; Anton-Culver H; Arndt V; ; Baynes C; Beckman MW; Benitez J; Van Den Berg D; Blot WJ; Bogdanova NV; Bojesen SE; Brenner H; Chang-Claude J; Chia KS; Choi JY; Conroy DM; Cox A; Cross SS; Czene K; Darabi H; Devilee P; Eriksson M; Fasching PA; Figueroa J; Flyger H; Fostira F; García-Closas M; Giles GG; Glendon G; González-Neira A; Guénel P; Haiman CA; Hall P; Hart SN; Hartman M; Hooning MJ; Hsiung CN; Ito H; Jakubowska A; James PA; John EM; Johnson N; Jones M; Kabisch M; Kang D; ; Kosma VM; Kristensen V; Lambrechts D; Li N; ; Lindblom A; Long J; Lophatananon A; Lubinski J; Mannermaa A; Manoukian S; Margolin S; Matsuo K; Meindl A; Mitchell G; Muir K; ; Nevelsteen I; van den Ouweland A; Peterlongo P; Phuah SY; Pylkäs K; Rowley SM; Sangrajrang S; Schmutzler RK; Shen CY; Shu XO; Southey MC; Surowy H; Swerdlow A; Teo SH; Tollenaar RA; Tomlinson I; Torres D; Truong T; Vachon C; Verhoef S; Wong-Brown M; Zheng W; Zheng Y; Nevanlinna H; Scott RJ; Andrulis IL; Wu AH; Hopper JL; Couch FJ; Winqvist R; Burwinkel B; Sawyer EJ; Schmidt MK; Rudolph A; Dörk T; Brauch H; Hamann U; Neuhausen SL; Milne RL; Fletcher O; Pharoah PD; Campbell IG; Dunning AM; Le Calvez-Kelm F; Goldgar DE; Tavtigian SV; Chenevix-Trench G
    J Med Genet; 2016 May; 53(5):298-309. PubMed ID: 26921362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the miR-17-5p variants with susceptibility to cervical cancer in a Chinese population.
    Jin T; Wu X; Yang H; Liu M; He Y; He X; Shi X; Wang F; Du S; Ma Y; Bao S; Yuan D
    Oncotarget; 2016 Nov; 7(47):76647-76655. PubMed ID: 27765929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK6 3'UTR polymorphisms alter the susceptibility to cervical cancer among Uyghur females.
    Aierken K; Dong Z; Abulimiti T; Zhang Y; Abuduxikuer G; Tuerxun G; Abudurexiti G; Maimaitiaishan A; Mijiti P; Abulizi G
    Mol Genet Genomic Med; 2019 May; 7(5):e626. PubMed ID: 30829464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of BARD1 and BRIP1 Gene Polymorphisms with the Risk of Uveal Melanoma.
    Mukhana L; Aissa AA; Ahmed AAM; Saakyan SV; Tsygankov AY; Blagonravov ML; Azova MM
    Bull Exp Biol Med; 2023 Jul; 175(3):399-403. PubMed ID: 37561379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in immune mediators associate with risk of cervical cancer.
    Zhang Z; Fye S; Borecki IB; Rader JS
    Gynecol Oncol; 2014 Oct; 135(1):69-73. PubMed ID: 25127987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence for the contribution of the BRCA1-interacting protein-terminal helicase 1 (BRIP1) gene in breast cancer susceptibility.
    Ren LP; Xian YS; Diao DM; Chen Y; Guo Q; Dang CX
    Genet Mol Res; 2013 Nov; 12(4):5793-801. PubMed ID: 24301948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study.
    Phelan CM; Iqbal J; Lynch HT; Lubinski J; Gronwald J; Moller P; Ghadirian P; Foulkes WD; Armel S; Eisen A; Neuhausen SL; Senter L; Singer CF; Ainsworth P; Kim-Sing C; Tung N; Llacuachaqui M; Chornokur G; Ping S; Narod SA;
    Br J Cancer; 2014 Jan; 110(2):530-4. PubMed ID: 24292448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate classification of BRCA1 variants with saturation genome editing.
    Findlay GM; Daza RM; Martin B; Zhang MD; Leith AP; Gasperini M; Janizek JD; Huang X; Starita LM; Shendure J
    Nature; 2018 Oct; 562(7726):217-222. PubMed ID: 30209399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the Oncogenic, Prognostic, and Immunological Role of BRIP1 in Pan-Cancer: A Comprehensive Data-Mining-Based Study.
    Liu Y; Wu X; Feng Y; Jiang Q; Zhang S; Wang Q; Yang A
    J Oncol; 2023; 2023():4104639. PubMed ID: 37153833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haplotypes of single cancer driver genes and their local ancestry in a highly admixed long-lived population of Northeast Brazil.
    Galisa SLG; Jacob PL; Farias AA; Lemes RB; Alves LU; Nóbrega JCL; Zatz M; Santos S; Weller M
    Genet Mol Biol; 2022; 45(1):e20210172. PubMed ID: 35112701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four common polymorphisms of BRIP1 (rs2048718, rs4988344, rs4986764, and rs6504074) and cancer risk: evidence from 13,716 cancer patients and 15,590 cancer-free controls.
    Liu D; Zheng Y; Wang M; Deng Y; Lin S; Zhou L; Yang P; Dai C; Xu P; Hao Q; Song D; Kang H; Dai Z
    Aging (Albany NY); 2018 Feb; 10(2):266-277. PubMed ID: 29466248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype.
    Carrera-Lasfuentes P; Lanas A; Bujanda L; Strunk M; Quintero E; Santolaria S; Benito R; Sopeña F; Piazuelo E; Thomson C; Pérez-Aisa A; Nicolás-Pérez D; Hijona E; Espinel J; Campo R; Manzano M; Geijo F; Pellise M; Zaballa M; González-Huix F; Espinós J; Titó L; Barranco L; D'Amato M; García-González MA
    Oncotarget; 2017 May; 8(22):35848-35862. PubMed ID: 28415781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Cancer Genetic Susceptibility: A Systematic Review and Meta-Analyses of Recent Evidence.
    Martínez-Nava GA; Fernández-Niño JA; Madrid-Marina V; Torres-Poveda K
    PLoS One; 2016; 11(7):e0157344. PubMed ID: 27415837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity.
    Zou W; Ma X; Hua W; Chen B; Huang Y; Wang D; Cai G
    Oncol Lett; 2016 Jan; 11(1):551-558. PubMed ID: 26870246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck.
    Liu H; Gao F; Dahlstrom KR; Li G; Sturgis EM; Zevallos JP; Wei Q; Liu Z
    Tumour Biol; 2016 Jun; 37(6):8057-66. PubMed ID: 26711789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Genetic Ancestral Composition Correlates with the Origin of Mycobacterium leprae Strains in a Leprosy Endemic Population.
    Cardona-Castro N; Cortés E; Beltrán C; Romero M; Badel-Mogollón JE; Bedoya G
    PLoS Negl Trop Dis; 2015; 9(9):e0004045. PubMed ID: 26360617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gDNA enrichment by a transposase-based technology for NGS analysis of the whole sequence of BRCA1, BRCA2, and 9 genes involved in DNA damage repair.
    Chevrier S; Boidot R
    J Vis Exp; 2014 Oct; (92):e51902. PubMed ID: 25350069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First evidence for the contribution of the genetic variations of BRCA1-interacting protein 1 (BRIP1) to the genetic susceptibility of cervical cancer.
    Ma XD; Cai GQ; Zou W; Huang YH; Zhang JR; Wang DT; Chen BL
    Gene; 2013 Jul; 524(2):208-13. PubMed ID: 23644138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRIP1 variations analysis reveals their relative importance as genetic susceptibility factor for cervical cancer.
    Ma XD; Cai GQ; Zou W; Huang YH; Zhang JR; Wang DT; Chen BL
    Biochem Biophys Res Commun; 2013 Apr; 433(2):232-6. PubMed ID: 23473757
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.